Studies in primary cancers other than PCa provide tissue-specific tumorigenic changes that can point to similarities between PCa and other primary tumors, as well as provide clues as to how to derive clinically relevant TF signatures. The gene discussed is TF; the disease is posterior cortical atrophy.